Developer docs
API playgroundTry for free, no card

Search company profiles

PRECISIONscientia

Full company profile

uuid000fufc

Namestring
PRECISIONscientia
Legal namestring
Precision AQ
Company typeenum
Private
Founded yearint
2002
Descriptiontext

PRECISIONscientia, doing business as Precision AQ, is a full-service medical communications and market access agency serving pharmaceutical and biotechnology companies. Founded in 2002 and headquartered in Yardley, Pennsylvania, the firm operates as an Agency of Record (AOR) for drug launches and label expansions, and claims involvement in approximately 50% of all FDA-approved drug launches in 2024. The primary customer segment is large pharmaceutical companies; biotechnology innovators form a secondary segment requiring support for therapy commercialization.

The firm's service portfolio is organized into six solution lines: Value & Access (Access Consulting, HEOR, Market Access Agency, Market Access Data Solutions), Medical Communications (Peer-to-Peer Marketing, Medical Affairs, Learning & Development), Investor Relations and External Communications, Brand Strategy and Marketing, Data Insights and Analytics, and Product Offerings. The proprietary product stack includes AccessGenius (payer and market access intelligence), OncoGenius (oncology-specific market intelligence), Data Solutions (patient, payer, provider analytics), EHR Solutions (electronic health record integration), and Omnichannel Solutions (multi-channel HCP, payer, patient engagement). Therapeutic specialization covers Immunology, Neurology, Oncology, Rare Disease, and Cardio Renal Metabolic. The technology is positioned as a data-integration and analytics platform rather than a discrete AI product.

Revenue is generated through professional services on a custom-quote basis, structured primarily as recurring AOR engagements. Distribution is direct enterprise field sales to pharma and biotech leadership; top-of-funnel marketing relies on LinkedIn, an integrated resources hub (reports, blog, videos), newsletter subscriptions, and industry events. Headcount sits at 101–250 employees, placing the firm in the mid-sized specialty agency tier. No public funding rounds, executive roster, M&A history, customer logos, or audited revenue figures are disclosed in the source data.

Short descriptiontext

PRECISIONscientia (operating as Precision AQ) is a full-service medical communications and market access agency serving pharmaceutical and biotechnology clients as Agency of Record for drug launches, label expansions, and HEOR evidence generation.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
101–250
akta.pro rankint
HeadquartersYardley, United States
HQ citystring
Yardley
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Keyword5 values
medical communications, market access consulting, pharmaceutical commercialization, HEOR evidence generation, medical affairs services
Industry4 codes
1Medical Affairs Scientific Communications (MSL Support/Scientific Response)
CodeHLAGALAFPrimaryYes
2Market Access, Pricing & Reimbursement (Evidence Generation) FSP
CodeHLAGAOANPrimaryNo
3Data Management, Biostatistics & Statistical Programming FSP
CodeHLAGAOABPrimaryNo
4Healthcare & Life Sciences PR
CodeMPAAADADPrimaryNo
NAICS code4 codes
  • Other Scientific and Technical Consulting Services54169
  • Custom Computer Programming Services541511
  • Computing Infrastructure Providers, Data Processing, Web Hosting, and Related Services51821
  • Other Scientific and Technical Consulting Services541690
SIC code2 codes
  • Services-Computer Programming, Data Processing, Etc.7370
  • Services-Prepackaged Software7372
Product category
Pharmaceutical Marketing Services
Social media profiles1 record
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1Professional Services
TypeProfessional Services
Description

Consulting and agency services including access consulting, HEOR, medical communications, investor relations, brand strategy, marketing, and data analytics. Operates as an Agency of Record providing ongoing strategic support for pharma commercialization.

precisionaq.com
Marketing channels4 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Operations, Technology or R&D, Marketing or Sales, Others
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

PRECISIONscientia (operating as Precision AQ) is a full-service medical communications and market access agency that helps pharmaceutical and biotechnology companies commercialize therapies. It delivers services spanning HEOR evidence generation, payer strategy, medical communications, medical affairs, brand strategy and marketing, investor relations, and data analytics, often serving as the Agency of Record for drug launches and label expansions. Its offering is augmented by proprietary technology products such as AccessGenius, OncoGenius, Data Solutions, EHR Solutions, and Omnichannel Solutions that evaluate market potential and support HCP, payer, and patient engagement.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 value
  • 50% of all FDA-approved drugs in 2024 were launched with Precision AQ
Product overview1 text field

Precision AQ offers a suite of technology products for pharmaceutical and biotech commercialization. The product portfolio includes AccessGenius, Data Solutions, EHR Solutions, Omnichannel Solutions, and OncoGenius—technology products that power HCP (healthcare provider), payer, and patient engagement by evaluating market potential, streamlining targeting, and supporting commercial impact. These products are complemented by consulting services including Access Consulting, HEOR, Market Access Agency, Medical Communications, Brand Strategy & Marketing, Investor Relations & External Communications, and Data, Insights, & Analytics.

Product and service9 records
1AccessGenius
CategoryMarket Access Technology
Description

Technology product that powers HCP, payer, and patient engagement by evaluating market potential and supporting commercial impact for pharmaceutical and biotech clients.

2OncoGenius
CategoryMarket Access Technology
Description

Specialized technology product delivering oncology-specific market intelligence and data solutions for oncology market access and commercialization support.

3Data Solutions
CategoryData Analytics Platform
Description

Technology product providing data analytics and insights for patient, payer, and provider segments to support market access and commercial success.

4EHR Solutions
CategoryHealth Data Integration
Description

Technology product providing electronic health record integration and data solutions for healthcare data integration and analysis.

5Omnichannel Solutions
CategoryEngagement Technology
Description

Technology product enabling multichannel engagement strategies for HCP, payer, and patient outreach across pharmaceutical and biotech commercial teams.

6Value & Access Services
CategoryConsulting Services
Description

Agency service line encompassing access consulting, HEOR, and market access agency services, delivering payer strategy, payer marketing, and evidence generation for pharmaceutical clients.

7Medical Communications Services
CategoryCommunications Services
Description

Agency service line covering peer-to-peer marketing, medical affairs, and learning and development communications for life sciences audiences.

8Investor Relations & External Communications
CategoryCommunications Services
Description

Service line delivering investor relations and public relations support to facilitate pharma and biotech engagement with the financial community and external audiences.

9Brand Strategy & Marketing
Scale indicator2 records

Each record includes

Type, Value, Description, Source

Recent move5 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Real Chemistry (formerly W2O) is a healthcare-focused agency combining data, analytics, PR, and medical communications for pharma and biotech, overlapping Precision AQ on communications, brand strategy, and data-driven engagement.

TypeBroad incumbent
Description

Publicis Health operates a global portfolio of health-focused agencies (including Saatchi & Saatchi Health, Digitas Health) covering medical communications, brand, and data — a broad incumbent competing for the same enterprise pharma AOR business.

TypeBroad incumbent
Description

IQVIA is the largest life sciences services conglomerate, spanning RWD, HEOR, market access, and commercial services — a broad incumbent that overlaps with most of Precision AQ's service portfolio, particularly data and access.

TypeDirect peer
Description

ZS Associates is a consulting firm specializing in pharma market access, sales, and data analytics — directly comparable to Precision AQ's access consulting, payer strategy, and data solutions practices.

TypeDirect peer
Description

Klick Health is a large independent health agency offering brand strategy, medical communications, omnichannel engagement, and data services — directly comparable to Precision AQ's brand, communications, and omnichannel offerings.

TypeDirect peer
Description

EVERSANA is an integrated pharma commercialization partner offering market access, medical communications, HEOR, and data/analytics — directly comparable to Precision AQ's end-to-end commercialization stack and customer base.

TypeDirect peer
Description

Fishawack Health is a medical communications and commercialization agency serving pharma across therapeutic areas, with deep scientific communications and HEOR offerings closely aligned to PRECISIONscientia's remit.

TypeBroad incumbent
Description

Havas Health is a global health communications and marketing network offering medical communications, advertising, and brand strategy — overlapping Precision AQ's brand, communications, and investor relations offerings at greater scale.

TypeBroad incumbent
Description

McKinsey's pharma and medical products practice provides market access, HEOR, and commercial strategy at the largest scale — a broad incumbent whose payer/HEOR work competes with Precision AQ's access consulting and HEOR teams.

TypeDirect peer
Description

Syneos Health combines clinical and commercial services, including medical communications and market access, serving similar pharma/biotech clients with an AOR-style commercialization model.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers1 record

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment2 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature5 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

PRECISIONscientia

Pharmaceutical Marketing Servicesprecisionscientia.com

PRECISIONscientia (operating as Precision AQ) is a full-service medical communications and market access agency serving pharmaceutical and biotechnology clients as Agency of Record for drug launches, label expansions, and HEOR evidence generation.

What PRECISIONscientia does

PRECISIONscientia, doing business as Precision AQ, is a full-service medical communications and market access agency serving pharmaceutical and biotechnology companies. Founded in 2002 and headquartered in Yardley, Pennsylvania, the firm operates as an Agency of Record (AOR) for drug launches and label expansions, and claims involvement in approximately 50% of all FDA-approved drug launches in 2024. The primary customer segment is large pharmaceutical companies; biotechnology innovators form a secondary segment requiring support for therapy commercialization.

The firm's service portfolio is organized into six solution lines: Value & Access (Access Consulting, HEOR, Market Access Agency, Market Access Data Solutions), Medical Communications (Peer-to-Peer Marketing, Medical Affairs, Learning & Development), Investor Relations and External Communications, Brand Strategy and Marketing, Data Insights and Analytics, and Product Offerings. The proprietary product stack includes AccessGenius (payer and market access intelligence), OncoGenius (oncology-specific market intelligence), Data Solutions (patient, payer, provider analytics), EHR Solutions (electronic health record integration), and Omnichannel Solutions (multi-channel HCP, payer, patient engagement). Therapeutic specialization covers Immunology, Neurology, Oncology, Rare Disease, and Cardio Renal Metabolic. The technology is positioned as a data-integration and analytics platform rather than a discrete AI product.

Revenue is generated through professional services on a custom-quote basis, structured primarily as recurring AOR engagements. Distribution is direct enterprise field sales to pharma and biotech leadership; top-of-funnel marketing relies on LinkedIn, an integrated resources hub (reports, blog, videos), newsletter subscriptions, and industry events. Headcount sits at 101–250 employees, placing the firm in the mid-sized specialty agency tier. No public funding rounds, executive roster, M&A history, customer logos, or audited revenue figures are disclosed in the source data.

PRECISIONscientia firmographics

Firmographics
Name
PRECISIONscientia
Legal name
Precision AQ
Website
https://precisionscientia.com
Company type
Private
Founded year
2002
Operating status
Operating
Headcount range
101–250 employees
Short description
PRECISIONscientia (operating as Precision AQ) is a full-service medical communications and market access agency serving pharmaceutical and biotechnology clients as Agency of Record for drug launches, label expansions, and HEOR evidence generation.
Ownership category
akta.pro rank

PRECISIONscientia industry classification

Industry
Product category
Pharmaceutical Marketing Services
NAICS
Other Scientific and Technical Consulting Services (54169), Custom Computer Programming Services (541511), Computing Infrastructure Providers, Data Processing, Web Hosting, and Related Services (51821), Other Scientific and Technical Consulting Services (541690)
SIC
Services-Computer Programming, Data Processing, Etc. (7370), Services-Prepackaged Software (7372)
akta.pro primary industry
Medical Affairs Scientific Communications (MSL Support/Scientific Response) (HLAGALAF)
akta.pro secondary industries
Market Access, Pricing & Reimbursement (Evidence Generation) FSP (HLAGAOAN), Data Management, Biostatistics & Statistical Programming FSP (HLAGAOAB), Healthcare & Life Sciences PR (MPAAADAD)

Keywords

  • Medical communications
  • Market access consulting
  • Pharmaceutical commercialization
  • HEOR evidence generation
  • Medical affairs services

Where PRECISIONscientia is headquartered

Location

Headquarters

HQ city
Yardley
HQ country
United States
HQ region
North America

Markets served

PRECISIONscientia business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Operations, Technology or R&D, Marketing or Sales, Others

Revenue model

  1. Professional Services: Consulting and agency services including access consulting, HEOR, medical communications, investor relations, brand strategy, marketing, and data analytics. Operates as an Agency of Record providing ongoing strategic support for pharma commercialization.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels4 records

PRECISIONscientia product offering

Product offering

Core offering

PRECISIONscientia (operating as Precision AQ) is a full-service medical communications and market access agency that helps pharmaceutical and biotechnology companies commercialize therapies. It delivers services spanning HEOR evidence generation, payer strategy, medical communications, medical affairs, brand strategy and marketing, investor relations, and data analytics, often serving as the Agency of Record for drug launches and label expansions. Its offering is augmented by proprietary technology products such as AccessGenius, OncoGenius, Data Solutions, EHR Solutions, and Omnichannel Solutions that evaluate market potential and support HCP, payer, and patient engagement.

Product overview

Precision AQ offers a suite of technology products for pharmaceutical and biotech commercialization. The product portfolio includes AccessGenius, Data Solutions, EHR Solutions, Omnichannel Solutions, and OncoGenius—technology products that power HCP (healthcare provider), payer, and patient engagement by evaluating market potential, streamlining targeting, and supporting commercial impact. These products are complemented by consulting services including Access Consulting, HEOR, Market Access Agency, Medical Communications, Brand Strategy & Marketing, Investor Relations & External Communications, and Data, Insights, & Analytics.

Differentiator

Problem solved

Functional benefit

Products and services

  • AccessGenius Technology product that powers HCP, payer, and patient engagement by evaluating market potential and supporting commercial impact for pharmaceutical and biotech clients.
  • OncoGenius Specialized technology product delivering oncology-specific market intelligence and data solutions for oncology market access and commercialization support.
  • Data Solutions Technology product providing data analytics and insights for patient, payer, and provider segments to support market access and commercial success.
  • EHR Solutions Technology product providing electronic health record integration and data solutions for healthcare data integration and analysis.
  • Omnichannel Solutions Technology product enabling multichannel engagement strategies for HCP, payer, and patient outreach across pharmaceutical and biotech commercial teams.
  • Value & Access Services Agency service line encompassing access consulting, HEOR, and market access agency services, delivering payer strategy, payer marketing, and evidence generation for pharmaceutical clients.
  • Medical Communications Services Agency service line covering peer-to-peer marketing, medical affairs, and learning and development communications for life sciences audiences.
  • Investor Relations & External Communications Service line delivering investor relations and public relations support to facilitate pharma and biotech engagement with the financial community and external audiences.
  • Brand Strategy & Marketing

Quantifiable outcome

  • 50% of all FDA-approved drugs in 2024 were launched with Precision AQ

Companies that use PRECISIONscientia

Customer profile

Named customers1 record

Segments2 records

Ideal customer profiles2 records

PRECISIONscientia technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature5 records

PRECISIONscientia partnerships and signals

Strategic signal

Scale indicators2 records

Recent moves5 records

Expansion highlights5 records

PRECISIONscientia competitors and assessment

Company assessment

Direct peers

  • Real Chemistry: Real Chemistry (formerly W2O) is a healthcare-focused agency combining data, analytics, PR, and medical communications for pharma and biotech, overlapping Precision AQ on communications, brand strategy, and data-driven engagement.
  • ZS Associates: ZS Associates is a consulting firm specializing in pharma market access, sales, and data analytics — directly comparable to Precision AQ's access consulting, payer strategy, and data solutions practices.
  • Klick Health: Klick Health is a large independent health agency offering brand strategy, medical communications, omnichannel engagement, and data services — directly comparable to Precision AQ's brand, communications, and omnichannel offerings.
  • EVERSANA: EVERSANA is an integrated pharma commercialization partner offering market access, medical communications, HEOR, and data/analytics — directly comparable to Precision AQ's end-to-end commercialization stack and customer base.
  • Fishawack Health: Fishawack Health is a medical communications and commercialization agency serving pharma across therapeutic areas, with deep scientific communications and HEOR offerings closely aligned to PRECISIONscientia's remit.
  • Syneos Health (ConcentricLife / Inotiv): Syneos Health combines clinical and commercial services, including medical communications and market access, serving similar pharma/biotech clients with an AOR-style commercialization model.

Broad incumbents

  • Publicis Health: Publicis Health operates a global portfolio of health-focused agencies (including Saatchi & Saatchi Health, Digitas Health) covering medical communications, brand, and data — a broad incumbent competing for the same enterprise pharma AOR business.
  • IQVIA: IQVIA is the largest life sciences services conglomerate, spanning RWD, HEOR, market access, and commercial services — a broad incumbent that overlaps with most of Precision AQ's service portfolio, particularly data and access.
  • Havas Health & You: Havas Health is a global health communications and marketing network offering medical communications, advertising, and brand strategy — overlapping Precision AQ's brand, communications, and investor relations offerings at greater scale.
  • McKinsey & Company (Pharma Practice): McKinsey's pharma and medical products practice provides market access, HEOR, and commercial strategy at the largest scale — a broad incumbent whose payer/HEOR work competes with Precision AQ's access consulting and HEOR teams.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

PRECISIONscientia social profiles

Digital presence

PRECISIONscientia financial estimates

Financial estimate

Revenue estimate

Valuation estimate

PRECISIONscientia leadership team

Management profile

Number of profiles

PRECISIONscientia funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

PRECISIONscientia M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about PRECISIONscientia

What does PRECISIONscientia do?

PRECISIONscientia (operating as Precision AQ) is a full-service medical communications and market access agency that helps pharmaceutical and biotechnology companies commercialize therapies. It delivers services spanning HEOR evidence generation, payer strategy, medical communications, medical affairs, brand strategy and marketing, investor relations, and data analytics, often serving as the Agency of Record for drug launches and label expansions. Its offering is augmented by proprietary technology products such as AccessGenius, OncoGenius, Data Solutions, EHR Solutions, and Omnichannel Solutions that evaluate market potential and support HCP, payer, and patient engagement.

Is PRECISIONscientia a public or private company?

PRECISIONscientia is a private company. It is classified as unknown and is currently operating.

When was PRECISIONscientia founded?

PRECISIONscientia was founded in 2002. It employs 101 to 250 people.

Where is PRECISIONscientia based?

PRECISIONscientia is headquartered in Yardley, United States, in the North America region.

How does PRECISIONscientia make money?

One revenue line is on record: professional Services.

Who are PRECISIONscientia's main competitors?

Direct peers on record are Real Chemistry, ZS Associates, Klick Health, EVERSANA, Fishawack Health and Syneos Health (ConcentricLife / Inotiv). Broad incumbents are Publicis Health, IQVIA, Havas Health & You and McKinsey & Company (Pharma Practice).

Does PRECISIONscientia have an API?

No public API is recorded for PRECISIONscientia.

What industry is PRECISIONscientia in?

PRECISIONscientia's product category is Pharmaceutical Marketing Services. Its primary akta.pro industry code is HLAGALAF, Medical Affairs Scientific Communications (MSL Support/Scientific Response), with a secondary code of HLAGAOAN, Market Access, Pricing & Reimbursement (Evidence Generation) FSP. Its NAICS code is 54169 and its SIC code is 7370.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
PR NewswirePRECISIONscientia Celebrates 20 Years of Communicating Breakthrough SciencePRECISIONscientia, a Pennsylvania-based medical communications agency and part of Precision Value & Health, is celebrating its 20th anniversary since founding in 2002. The agency has partnered with over 100 pharmaceutical and biotech companies, supporting more than 200 brands and over 60 rare diseases, including cell and gene therapies and a first-in-class CAR T-cell therapy. The company, which employs more than 230 people and has been recognized as a Best Places to Work for three consecutive years, attributes its success to helping translate complex science for healthcare providers and patients.PR NewswirePRECISIONscientia Named Among "Best Places to Work" for a Third Consecutive YearPRECISIONscientia, a Pennsylvania-based medical communications agency, was selected by the Philadelphia Business Journal for the 2022 "Best Places to Work" Awards in the large company category, marking the third consecutive year of recognition. The award is based on employee assessments of workplace culture, professional environment, and engagement levels. The company credited its talented workforce and collaborative culture as the foundation for this achievement.PR NewswirePRECISIONscientia Announces Organizational Changes to Advance Strategic Digital Engagement, Client Partnership and SatisfactionPRECISIONscientia announced two personnel changes to advance its strategic growth plans: Kurt Mueller was elevated to Senior Vice President of Digital Engagement, where he will oversee all digital engagement efforts and lead integration of the recent acquisition of Across Health, a global omnichannel engagement consultancy. Nicole Ramocki was promoted to Vice President of Client Services after more than 11 years with the agency, where she will lead client services operations. The changes are framed as part of PRECISIONscientia's vision to set a new industry standard for medical communications.PR NewswirePRECISIONscientia Recognized as One of the Philadelphia Business Journal's 2020 Best Places to WorkPRECISIONscientia, a Pennsylvania-based medical communications agency, has been recognized as a recipient of the Philadelphia Business Journal's 2020 Best Places to Work Awards in the large company category for companies with 100-499 employees in the Greater Philadelphia area. The award was determined through employee surveys rating the company on work environment, growth opportunities, professional environment, people, and innovation culture. Managing Director Nate Wible stated that the company is proud of the recognition and committed to maintaining its collaborative and innovative work environment as it continues to expand.PR NewswirePRECISIONscientia's Nicole Ramocki Honored as 2020 PM360 ELITE 100 "Launch Expert" Award WinnerPRECISIONscientia announced that its Vice President Nicole Ramocki was selected as a 2020 PM360 ELITE 100 'Launch Expert' winner. The recognition highlights her role in successfully launching novel therapies, including a CAR T-cell therapy for pediatric leukemia and an oral treatment for relapsing Multiple Sclerosis. The award is part of the sixth annual PM360 ELITE Awards, which honor influential individuals in the healthcare industry.PR NewswireETHOS Health Communications Changes Name to PRECISIONscientia, Reflects Commitment to Scientific Accuracy and ClarityETHOS Health Communications has officially changed its name to PRECISIONscientia to better reflect its commitment to scientific accuracy and alignment with its parent company, Precision Value & Health. The rebranding coincides with the promotion of co-founder Nate Wible to executive vice president and managing director as Anita O'Connor retires.